Clinical Trial Update: Prophylactic Effects of Agomelatine for Poststroke Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating prophylactic effects of agomelatine for post-stroke depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Stroke

Drugs mentioned

• Agomelatine (agomelatine)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Depression, Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN